A study to test COVID-19 drug Molnupiravir is set to be conducted in the Philippines by the second week of November.  The drug was developed by pharmaceutical company Merck and Ridgeback Biotherapeutics in the United States and Canada. RELATED STORY: Merck applies for US authorization for first COVID-19 pill President of the Pharmaceutical & Healthcare …

The post Philippines to test efficacy of COVID treatment pill  appeared first on The Filipino Times.